Literature DB >> 16362348

Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population.

Yu-Lin Ko1, Lung-An Hsu, Tsu-Shiu Hsu, Chia-Ti Tsai, Ming-Sheng Teng, Semon Wu, Chi-Jen Chang, Ying-Shiung Lee.   

Abstract

To determine the genetic risk factors for venous thromboembolism (VTE), this study examined 14 genetic variants from 10 hemostatic genes in 186 Taiwanese VTE patients and the same number of matched controls, which demonstrated FGA (encoding alpha fibrinogen) Thr312Ala polymorphism was the only variant significantly associated with VTE. Nine genetic polymorphisms on the fibrinogen cluster region of chromosome 4q28 were further studied, in which four FGA polymorphisms were found in strong linkage disequilibrium and were significantly associated with VTE by genotype and allele frequency analyses. Haplotype analysis showed significantly different FGA haplotype frequencies between VTE patients and controls with the haplotype F1, containing -1051G, -3A, 312Ala and TaqI duplication alleles, significantly associated with susceptibility to VTE (P = 0.001). Haplotype-pair analysis results also indicated a strong association of the haplotype-pair F1F1 with VTE in various VTE patient subgroups. In vitro functional analysis indicated that FGA -1051G, -3A and TaqI duplication alleles enhanced significantly the transcription level of FGA; however, control subjects with FGA genotypes containing these alleles had no elevated plasma fibrinogen levels. In conclusion, our experimental data indicated that functional genetic variants in FGA are risk factors for VTE in Taiwanese populations. Determination of FGA genotypes will likely contribute to primary prevention of this condition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362348     DOI: 10.1007/s00439-005-0102-0

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  36 in total

1.  Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk.

Authors:  Bernard C B Lim; Robert A S Ariëns; Angela M Carter; John W Weisel; Peter J Grant
Journal:  Lancet       Date:  2003-04-26       Impact factor: 79.321

2.  Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration.

Authors:  F M van 't Hooft; S J von Bahr; A Silveira; A Iliadou; P Eriksson; A Hamsten
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-12       Impact factor: 8.311

3.  Variation in plasma fibrinogen over one year: relationships with genetic polymorphisms and non-genetic factors.

Authors:  S Väisänen; R Rauramaa; I Penttilä; T Rankinen; J Gagnon; L Pérusse; M Chagnon; C Bouchard
Journal:  Thromb Haemost       Date:  1997-05       Impact factor: 5.249

4.  Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.

Authors:  J Voorberg; J Roelse; R Koopman; H Büller; F Berends; J W ten Cate; K Mertens; J A van Mourik
Journal:  Lancet       Date:  1994-06-18       Impact factor: 79.321

5.  Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions.

Authors:  P W Kamphuisen; J C Eikenboom; H L Vos; R Pablo; A Sturk; R M Bertina; F R Rosendaal
Journal:  Thromb Haemost       Date:  1999-05       Impact factor: 5.249

6.  Mutations in promoter region of thrombomodulin and venous thromboembolic disease.

Authors:  L Le Flem; V Picard; J Emmerich; S Gandrille; J N Fiessinger; M Aiach; M Alhenc-Gelas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-04       Impact factor: 8.311

7.  Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolism.

Authors:  E Arnaud; V Nicaud; O Poirier; F Rendu; M Alhenc-Gelas; J N Fiessinger; J Emmerich; M Aiach
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

8.  Fibrinogen genotypes (alpha and beta) are associated with plasma fibrinogen levels in Chinese.

Authors:  Y Liu; N Saha; C K Heng; S Hong; P S Low
Journal:  J Med Genet       Date:  2001-09       Impact factor: 6.318

9.  alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism.

Authors:  A M Carter; A J Catto; H P Kohler; R A Ariëns; M H Stickland; P J Grant
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

10.  The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity.

Authors:  S Kangsadalampai; P G Board
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

View more
  9 in total

1.  Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen alpha gene.

Authors:  Zhiyong Chen; Toshiaki Nakajima; Nobuhiro Tanabe; Kunihiko Hinohara; Seiichiro Sakao; Yasunori Kasahara; Koichiro Tatsumi; Yoshinori Inoue; Akinori Kimura
Journal:  Hum Genet       Date:  2010-07-31       Impact factor: 4.132

2.  The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study.

Authors:  Laura J Rasmussen-Torvik; Mary Cushman; Michael Y Tsai; Yan Zhang; Susan R Heckbert; Wayne D Rosamond; Aaron R Folsom
Journal:  Thromb Res       Date:  2007-04-11       Impact factor: 3.944

3.  Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease.

Authors:  Ana Bronić; Goran Ferenčak; Robert Bernat; Jasna Leniček-Krleža; Jerka Dumić; Sanja Dabelić
Journal:  J Med Biochem       Date:  2021-03-12       Impact factor: 3.402

Review 4.  The role of ethnicity, age and gender in venous thromboembolism.

Authors:  Martina Montagnana; Emmanuel J Favaloro; Massimo Franchini; Gian Cesare Guidi; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

Review 5.  Genetic risk factors for spontaneous intracerebral haemorrhage.

Authors:  Amanda M Carpenter; Inder P Singh; Chirag D Gandhi; Charles J Prestigiacomo
Journal:  Nat Rev Neurol       Date:  2015-12-16       Impact factor: 42.937

6.  Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes.

Authors:  Luca A Lotta; Mark Wang; Jin Yu; Ida Martinelli; Fuli Yu; Serena M Passamonti; Dario Consonni; Emanuela Pappalardo; Marzia Menegatti; Steven E Scherer; Lora L Lewis; Humeira Akbar; Yuanqing Wu; Matthew N Bainbridge; Donna M Muzny; Pier M Mannucci; Richard A Gibbs; Flora Peyvandi
Journal:  BMC Med Genomics       Date:  2012-02-21       Impact factor: 3.063

7.  Association of vWA and TPOX polymorphisms with venous thrombosis in Mexican mestizos.

Authors:  Marco Antonio Meraz-Ríos; Abraham Majluf-Cruz; Carla Santana; Gino Noris; Rafael Camacho-Mejorado; Leonor C Acosta-Saavedra; Emma S Calderón-Aranda; Jesús Hernández-Juárez; Jonathan J Magaña; Rocío Gómez
Journal:  Biomed Res Int       Date:  2014-08-31       Impact factor: 3.411

Review 8.  Associations between polymorphisms in coagulation-related genes and venous thromboembolism: A meta-analysis with trial sequential analysis.

Authors:  Jun Jiang; Kang Liu; Junjie Zou; Hao Ma; Hongyu Yang; Xiwei Zhang; Yuanyong Jiao
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

9.  Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencing.

Authors:  Zuzana Chyra Kufova; Tereza Sevcikova; Jaroslav Januska; Petr Vojta; Arpad Boday; Pavla Vanickova; Jana Filipova; Katerina Growkova; Tomas Jelinek; Marian Hajduch; Roman Hajek
Journal:  J Clin Pathol       Date:  2018-02-17       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.